Brief introduction of Guangzhou Brilliance

Medical Technology Co., Ltd

Guangzhou Brilliance Medical Technology Co., Ltd. is an enterprise specializing in the production of plastic injection molding parts for medical devices. It was established in June 2020 and is located in the Science City, a high-tech enterprise circle in Guangzhou. Our team has been committed to the medical consumables market, inheriting the excellent tradition and technical strength of the brother company ‘Secure plastic’ (established in 2009), pioneering and enterprising, determined to innovate, expand production capacity, and constantly meet the needs of customers and the market.

During the past 10 years, we attaches great importance to technology research and development and technological innovation, and our products are welcomed by several major customers of listed companies. At present, we have the following best-selling products:

A. Specimen Preservation Reagent (1.5ml/bottle, 3ml/bottle, 5ml/bottle, 10ml/bottle)

B. Specimen collection flocked swabs 

C. Specimen preservation tube containing

D. Dispensable hemodialysis pipelines
E. Dispensable safety syringes
F. Examination consumables for hospitals or labs

We adhere to the "customer first" concept, starting from creating customer value and social value, so as to enhance enterprise value. We always attaches great importance to the development of employees' ability and stimulates their potential. Through the performance reward system, the company is willing to share the achievements of the company's growth with all the employees who have made contributions, and pursue the realization of employees' value. We attach importance to the development of win-win industrial platform, honor and grow together with all partners. We promote the healthy and long-term development of the company by professionalization and standardization. Through mature and effective marketing and management mechanism, we can achieve sustained interest growth, care for the society and give back to the society, so as to promote the development of China's health industry.